{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T06:37:23Z","timestamp":1777012643363,"version":"3.51.4"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Colorectal cancer (CRC) remains a leading cause of cancer-related death worldwide. Primary sclerosing cholangitis (PSC) increases the risk of CRC, but the biological link is not well understood. Changes in the gut-liver axis, including gut microbiota and microbial metabolites, may contribute to CRC development in PSC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To explore pathways connecting PSC with CRC through gut microbiota signals, and to identify candidate host genes for follow-up analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Mendelian randomization (MR) was used to estimate the causal effect of genetically predicted PSC on CRC risk and to test associations between PSC liability and gut microbial traits. Mediation analyses were performed to assess whether specific microbial features may contribute to the PSC-CRC association. Single-cell RNA sequencing (scRNA-seq) data from PSC and CRC were integrated to screen candidate host genes, which were further evaluated using survival analyses and immunohistochemistry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      MR supported a causal association between PSC and higher CRC risk (\n                      <jats:italic>OR<\/jats:italic>\n                      = 1.172, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      : 1.033\u20131.329,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.014). Genetically predicted PSC was associated with changes in gut microbial composition, with the\n                      <jats:italic>family Lachnospiraceae<\/jats:italic>\n                      emerging as a notable feature. Within these signals, the\n                      <jats:italic>genus Lachnospiraceae FCS020 group<\/jats:italic>\n                      was associated with CRC risk (\n                      <jats:italic>OR<\/jats:italic>\n                      = 1.237, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      : 1.004\u20131.523,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.045) and partially mediated the PSC-CRC association (mediating proportion 13.7%, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      : 1.0%\u221268.1%; indirect effect 0.021, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      : 0.000\u20130.054). In scRNA-seq analyses, PCBP1 emerged as a shared signal across PSC and CRC programs and was linked to butyrate related gene signatures. Higher PCBP1 expression was associated with poorer overall survival (OS) and recurrence-free survival (RFS) in CRC, and PCBP1 showed a positive association with PD-L1 by immunohistochemistry in an exploratory analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      These findings provide supportive evidence that gut microbiota changes and host gene signals are linked to the PSC\u2013CRC association.\n                      <jats:italic>Lachnospiraceae<\/jats:italic>\n                      related microbial features and PCBP1 warrant further validation. Studies in independent cohorts and mechanistic models will be important to clarify functional specificity and clinical utility.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmicb.2026.1781475","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T05:41:52Z","timestamp":1777009312000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Gut microbiota pathways linking primary sclerosing cholangitis to colorectal cancer: the Lachnospiraceae family and PCBP1"],"prefix":"10.3389","volume":"17","author":[{"given":"Zhaobin","family":"He","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary Surgery, Qilu Hospital of Shandong University, Jinan","place":["Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Qinghai Red Cross Hospital, Xining","place":["Qinghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqiang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Qinghai Red Cross Hospital, Xining","place":["Qinghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Qinghai Red Cross Hospital, Xining","place":["Qinghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoguang","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Qinghai Red Cross Hospital, Xining","place":["Qinghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Qilu Hospital of Shandong University, Jinan","place":["Shandong, China"]},{"name":"Department of Hepatobiliary Surgery, Qinghai Red Cross Hospital, Xining","place":["Qinghai, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1136\/gutjnl-2024-333353","article-title":"Low-coverage whole genome sequencing of low-grade dysplasia strongly predicts advanced neoplasia risk in ulcerative colitis","volume":"74","author":"Al Bakir","year":"2025","journal-title":"Gut"},{"key":"B2","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1136\/gutjnl-2021-326500","article-title":"Protective and aggressive bacterial subsets and metabolites modify hepatobiliary inflammation and fibrosis in a murine model of PSC","volume":"72","author":"Awoniyi","year":"2023","journal-title":"Gut"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.chom.2024.07.008","article-title":"Navigating beyond associations: opportunities to establish causal relationships between the gut microbiome and colorectal carcinogenesis","volume":"32","author":"Baas","year":"2024","journal-title":"Cell Host Microbe"},{"key":"B4","doi-asserted-by":"publisher","first-page":"4548","DOI":"10.3748\/wjg.v23.i25.4548","article-title":"Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis","volume":"23","author":"Bajer","year":"2017","journal-title":"World J. Gastroenterol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.14309\/ajg.0000000000001941","article-title":"Inflammatory bowel disease-associated colorectal cancer epidemiology and outcomes: an English population-based study","volume":"117","author":"Birch","year":"2022","journal-title":"Am. J. Gastroenterol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.3390\/nu13031018","article-title":"The gut-liver axis in cholestatic liver diseases","volume":"13","author":"Blesl","year":"2021","journal-title":"Nutrients"},{"key":"B7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s40168-025-02028-7","article-title":"The intestinal microbiome and metabolome discern disease severity in cytotoxic T-lymphocyte-associated protein 4 deficiency","volume":"13","author":"Chandrasekaran","year":"2025","journal-title":"Microbiome"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1136\/gutjnl-2020-323476","article-title":"Integrated analysis of the faecal metagenome and serum metabolome reveals the role of gut microbiome-associated metabolites in the detection of colorectal cancer and adenoma","volume":"71","author":"Chen","year":"2022","journal-title":"Gut"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2022.106312","article-title":"Fecal 16S rRNA sequencing and multi-compartment metabolomics revealed gut microbiota and metabolites interactions in APP\/PS1 mice","author":"Cheng","year":"2022","journal-title":"Comput. Biol. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1348027","DOI":"10.3389\/fmicb.2024.1348027","article-title":"Association between gut microbiota and autoimmune cholestatic liver disease, a Mendelian randomization study","volume":"15","author":"Cui","year":"2024","journal-title":"Front. Microbiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2374596","DOI":"10.1080\/19490976.2024.2374596","article-title":"Microbiome and pancreatic cancer: time to think about chemotherapy","volume":"16","author":"de Castilhos","year":"2024","journal-title":"Gut Microbes"},{"key":"B12","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/hep.30085","article-title":"Primary sclerosing cholangitis risk estimate tool (PREsTo) predicts outcomes of the disease: a derivation and validation study using machine learning","volume":"71","author":"Eaton","year":"2020","journal-title":"Hepatology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","article-title":"Targeting PI3K\/Akt signal transduction for cancer therapy","volume":"6","author":"He","year":"2021","journal-title":"Signal Transduct. Target Ther"},{"key":"B14","doi-asserted-by":"publisher","first-page":"7937","DOI":"10.3390\/ijms25147937","article-title":"Gut microbiota signatures in colorectal cancer as a potential diagnostic biomarker in the future: a systematic review","volume":"25","author":"Herlo","year":"2024","journal-title":"Int. J. Mol. Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/hep.32773","article-title":"A shared mucosal gut microbiota signature in primary sclerosing cholangitis before and after liver transplantation","volume":"77","author":"Hole","year":"2023","journal-title":"Hepatology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e2502634","DOI":"10.1002\/advs.202502634","article-title":"Gut microbiota modulates obesity-associated skeletal deterioration through macrophage aging and grancalcin secretion","volume":"12","author":"Huang","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2078620","DOI":"10.1080\/19490976.2022.2078620","article-title":"Fecal microbiota and bile acids in IBD patients undergoing screening for colorectal cancer","volume":"14","author":"Lavelle","year":"2022","journal-title":"Gut Microbes"},{"key":"B18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41421-025-00789-x","article-title":"A decrease in flavonifractor plautii and its product, phytosphingosine, predisposes individuals with phlegm-dampness constitution to metabolic disorders","volume":"11","author":"Li","year":"2025","journal-title":"Cell Discov"},{"key":"B19","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The molecular signatures database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"B20","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12877-023-03793-6","article-title":"EIF5A2 specifically regulates the transcription of aging-related genes in human neuroblastoma cells","volume":"23","author":"Liu","year":"2023","journal-title":"BMC Geriatr"},{"key":"B21","doi-asserted-by":"publisher","first-page":"111116","DOI":"10.1016\/j.isci.2024.111116","article-title":"Gut commensal Agathobacter rectalis alleviates microglia-mediated neuroinflammation against pathogenesis of Alzheimer disease","volume":"27","author":"Lv","year":"2024","journal-title":"iScience"},{"key":"B22","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/s41419-024-07152-0","article-title":"The link between amyloid \u03b2 and ferroptosis pathway in Alzheimer's disease progression","volume":"15","author":"Majern\u00edkov\u00e1","year":"2024","journal-title":"Cell Death Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.3390\/nu15061433","article-title":"Industrial and ruminant trans-fatty acids-enriched diets differentially modulate the microbiome and fecal metabolites in C57BL\/6 mice","volume":"15","author":"Mohammadi","year":"2023","journal-title":"Nutrients"},{"key":"B24","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12876-021-01741-5","article-title":"Evaluation of circulating cell-free DNA in cholestatic liver disease using liver-specific methylation markers","volume":"21","author":"Punia","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1093\/ecco-jcc\/jjaa021","article-title":"A pilot integrative analysis of colonic gene expression, gut microbiota, and immune infiltration in primary sclerosing cholangitis-inflammatory bowel disease: association of disease with bile acid pathways","volume":"14","author":"Quraishi","year":"2020","journal-title":"J. Crohns Colitis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"jjae189","DOI":"10.1093\/ecco-jcc\/jjae189","article-title":"Open label vancomycin in primary sclerosing cholangitis-inflammatory bowel disease: improved colonic disease activity and associations with changes in host-microbiome-metabolomic signatures","volume":"19","author":"Quraishi","year":"2025","journal-title":"J. Crohns Colitis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3390\/life15060967","article-title":"Novel acylated naringin enhances propionate release and stimulates the growth of flavanone-metabolizing bacteria in an in vitro batch fermentation model","volume":"15","author":"Ruiz-\u00c1lvarez","year":"2025","journal-title":"Life (Basel)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41419-023-05853-6","article-title":"Butyrate limits inflammatory macrophage niche in NASH","volume":"14","author":"Sarkar","year":"2023","journal-title":"Cell Death Dis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13046-018-0840-1","article-title":"PCBP1 depletion promotes tumorigenesis through attenuation of p27Kip1 mRNA stability and translation","volume":"37","author":"Shi","year":"2018","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3390\/cells14030166","article-title":"Promising cellular immunotherapy for colorectal cancer using classical dendritic cells and natural killer T cells","volume":"14","author":"Singer","year":"2025","journal-title":"Cells"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1243834","DOI":"10.3389\/fimmu.2023.1243834","article-title":"Astragalus improves intestinal barrier function and immunity by acting on intestinal microbiota to treat T2DM: a research review","volume":"14","author":"Su","year":"2023","journal-title":"Front. Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"901559","DOI":"10.3389\/fphar.2022.901559","article-title":"Effects of GLP-1 receptor agonists on biological behavior of colorectal cancer cells by regulating PI3K\/AKT\/mTOR signaling pathway","volume":"13","author":"Tong","year":"2022","journal-title":"Front. Pharmacol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.3390\/foods10092040","article-title":"Impact of plant-based meat alternatives on the gut microbiota of consumers: a real-world study","volume":"10","author":"Toribio-Mateas","year":"2021","journal-title":"Foods"},{"key":"B34","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jhep.2023.09.031","article-title":"Inflammatory bowel disease and primary sclerosing cholangitis: one disease or two?","volume":"80","author":"van Munster","year":"2024","journal-title":"J. Hepatol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"111221","DOI":"10.1016\/j.mce.2021.111221","article-title":"The regulation of RNA metabolism in hormone signaling and breast cancer","volume":"529","author":"Wang","year":"2021","journal-title":"Mol. Cell Endocrinol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"5555","DOI":"10.3748\/wjg.v27.i33.5555","article-title":"Gut microbiota-derived metabolites as key mucosal barrier modulators in obesity","volume":"27","author":"Wei","year":"2021","journal-title":"World J. Gastroenterol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"7464","DOI":"10.1038\/s41467-025-62880-x","article-title":"A hollow-tube-like hydrospongel for multimodal therapy of advanced colorectal cancer","volume":"16","author":"Wu","year":"2025","journal-title":"Nat. Commun"},{"key":"B38","doi-asserted-by":"publisher","first-page":"759323","DOI":"10.3389\/fimmu.2021.759323","article-title":"Integrating serum metabolome and gut microbiome to evaluate the benefits of lauric acid on lipopolysaccharide\u2014challenged broilers","volume":"12","author":"Wu","year":"2021","journal-title":"Front. Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/j.chom.2025.07.019","article-title":"Veillonella intestinal colonization promotes C. difficile infection in Crohn's disease","volume":"33","author":"Yang","year":"2025","journal-title":"Cell Host Microbe"},{"key":"B40","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s00535-024-02169-w","article-title":"Anti-integrin \u03b1v\u03b26 autoantibody in primary sclerosing cholangitis: a Japanese nationwide study","volume":"60","author":"Yasuda","year":"2025","journal-title":"J. Gastroenterol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41392-025-02296-7","article-title":"Acevaltrate as a novel ferroptosis inducer with dual targets of PCBP1\/2 and GPX4 in colorectal cancer","volume":"10","author":"Yu","year":"2025","journal-title":"Signal Transduct. Target Ther"},{"key":"B42","doi-asserted-by":"publisher","author":"Zhang","year":"2025","DOI":"10.1016\/j.ijbiomac.2025.147976"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e05396","DOI":"10.1002\/advs.202505396","article-title":"Hypoxia-induced circPRELID2 promotes gastric cancer metastasis by facilitating ZEB2 translation via PCBP1 O-GlcNAcylation","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"B44","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13020-024-00978-y","article-title":"Exploring the immunometabolic potential of Danggui Buxue Decoction for the treatment of IBD-related colorectal cancer","volume":"19","author":"Zhang","year":"2024","journal-title":"Chin. Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"216828","DOI":"10.1016\/j.canlet.2024.216828","article-title":"LncRNA GAS6-AS1 contributes to 5-fluorouracil resistance in colorectal cancer by facilitating the binding of PCBP1 with MCM3","volume":"589","author":"Zhu","year":"2024","journal-title":"Cancer Lett"},{"key":"B46","doi-asserted-by":"publisher","first-page":"157264","DOI":"10.1016\/j.phymed.2025.157264","article-title":"Pathogenic mechanisms of cerebral ischemia and potential gut-brain axis-oriented therapeutic strategies","volume":"148","author":"Zhuang","year":"2025","journal-title":"Phytomedicine"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1781475\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T05:41:56Z","timestamp":1777009316000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1781475\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":46,"alternative-id":["10.3389\/fmicb.2026.1781475"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2026.1781475","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"article-number":"1781475"}}